Total Credits: .75 including 0.75 AOA Category 1-A Credit(s)
The goal is to familiarize the audience with the therapeutic advances in Neurology which are applicable across specialties and diseases. We will focus on the use of antisense oligonucleotides in the treatment of different disease with special emphasis on Huntington's disease. We will spend time gain an understanding of Huntington's disease and implications of the disease in order to appreciate the impact such a treatment option would have for this patient populations and populations alike.
Learning Objectives:
1. Introduction to Huntington's disease as a lead in to how we might be able to change the course of this disease
2. Learn about the emerging field of the therapeutic use of antisense oligonucleotide
3. Discuss the application of antisense oligonucleotide in neurological diseases
4. Understand the application and impact of antisense oligonucleotides in Huntington's disease.
Accreditation:
OPSC is accredited by the American Osteopathic Association to provide osteopathic continuing medical education for physicians. OPSC designates this program for the a maximum of one (1) hour of AOA Category 1-A credits and will report CME and speciality credits commensurate with the extent of the physician's participation in this activity.
| Duffy.pdf (6.00 MB) | Available after Purchase | ||
Dr. Duffy completed her Internship at Alameda County Medical Center and then her Neurology Residency at UC Davis Medical Center. She stayed at UC Davis under the mentorship of Dr. Vicki Wheelock to complete a fellowship in Movement Disorders with an emphasis in Huntington’s disease. She then joined the Neurology Department at UC Davis as an Assistant Clinical Professor where she has continued her practice in Movement Disorders. She has pursued her research interests in Huntington’s disease participating in a number of clinical trials. Additionally, she has a keen interest in education and serves and the Neurology Residency Program Director where she oversees and participates in the training of the neurology residents at UC Davis.